Nazak Michael Adrian 4
4 · AN2 Therapeutics, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Nazak Michael Adrian
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-15+16,600→ 16,600 totalExercise: $14.29Exp: 2033-02-14→ Common Stock (16,600 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.